Insiders / Holuka Eugene Myron
Holuka Eugene Myron
CIK 1678292personinsider
Companies
2
First seen
Feb 18, 2021
Last activity
Dec 22, 2025
Companies
| Company | Shares held | Latest |
|---|---|---|
| Citius Oncology, Inc. · CTOR | 300,000 | — |
| Citius Pharmaceuticals, Inc. · CTXR | 2,367 | — |
All securities held
4 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Citius Oncology, Inc. | Common stock | 300,000 |
| Citius Pharmaceuticals, Inc. | Common stock | 2,367 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Citius Oncology, Inc. | Options | 150,000 |
| Citius Pharmaceuticals, Inc. | Options | 13,334 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Mar 13, 2024 | Exercise Option exercise | CTXR Citius Pharmaceuticals, Inc. Common Stock | $36 | +2K | 2,415 <0.01% of shares | low |
| Mar 13, 2024 | Other Withheld for taxes | CTXR Citius Pharmaceuticals, Inc. Common Stock | $36 | -48 -1.99% | 2,367 <0.01% of shares | low |
| Sep 19, 2025 | Grant Grant or award | CTOR Citius Oncology, Inc. Common Stock | $0 |